KPX Lifescience.Co.Ltd (114450) — Financial Flexibility Index
KPX Lifescience.Co.Ltd (114450) has a Financial Flexibility Index of 0.24x as of September 2025. Free cash flow of ₩3.61 Billion (operating CF ₩3.33 Billion minus capex ₩275.98 Million) represents 0% of total liabilities (₩15.22 Billion). Check KPX Lifescience.Co.Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
KPX Lifescience.Co.Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for KPX Lifescience.Co.Ltd across 11 annual periods. See how liquid is KPX Lifescience.Co.Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for KPX Lifescience.Co.Ltd. For the full company profile including market capitalisation, see 114450 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | ₩988.20 Million | ₩525.49 Million | ₩9.22 Billion | ▼ -0.2% |
| 2023 | 0.11x | ₩845.04 Million | ₩370.02 Million | ₩7.87 Billion | ▲ +134.2% |
| 2022 | -0.31x | ₩-3.07 Billion | ₩-4.55 Billion | ₩9.79 Billion | ▼ -221.4% |
| 2021 | 0.26x | ₩4.06 Billion | ₩611.38 Million | ₩15.68 Billion | ▼ -35.1% |
| 2020 | 0.40x | ₩4.57 Billion | ₩1.90 Billion | ₩11.48 Billion | ▼ -41.4% |
| 2019 | 0.68x | ₩7.84 Billion | ₩4.24 Billion | ₩11.54 Billion | ▼ -45.8% |
| 2018 | 1.25x | ₩12.87 Billion | ₩5.38 Billion | ₩10.26 Billion | ▲ +36.5% |
| 2017 | 0.92x | ₩9.99 Billion | ₩5.68 Billion | ₩10.87 Billion | ▲ +63.2% |
| 2016 | 0.56x | ₩8.67 Billion | ₩7.07 Billion | ₩15.39 Billion | ▼ -6.0% |
| 2015 | 0.60x | ₩6.14 Billion | ₩5.62 Billion | ₩10.25 Billion | ▲ +81.4% |
| 2014 | 0.33x | ₩4.92 Billion | ₩4.09 Billion | ₩14.90 Billion | — |